Macromo

Macromo operates within the preventative healthcare and longevity sector, offering a platform that synthesizes diverse health data to provide personalized wellness insights. The company was founded in 2021 in Prague, Czech Republic, by Petr Stepanek, Eva Kuttichova, and Michal Pohludka. The founding idea stemmed from Stepanek, a bioinformatician, who after sequencing his own genome, realized the untapped potential of combining genetic data with other lifestyle factors to forecast and manage health. The co-founding team brings a blend of expertise, with Kuttichova's background in product design from Silicon Valley tech companies and Pohludka's extensive experience in the diagnostics industry.

The core of Macromo's business is a mobile application that functions as a central hub for a user's health information. It integrates data from at-home DNA and blood tests, wearables, and manually imported medical records to generate tailored lifestyle recommendations. This service targets health-conscious individuals, particularly users of wearables and biohackers, who are keen to proactively manage their health and mitigate long-term risks. Revenue is generated through the direct-to-consumer sale of various at-home testing kits, such as DNA analysis and blood panels for specific health areas like heart and liver function, and through app subscriptions. The company has expanded its product availability through major distributors and pharmacies across nine European countries.

Macromo's platform is designed to make complex health data actionable and understandable for the user. By applying machine learning and a proprietary AI model to the aggregated data, the app provides a detailed overview of an individual's health risks and personalized protocols to address them. For instance, users have identified and managed risks for high cholesterol and cardiovascular disease by following the app's guidance. A significant milestone was achieved in April 2025, when Macromo was acquired by TCF Capital, a firm founded by Tomáš Čupr, the founder of the Czech unicorn Rohlík. This strategic acquisition is part of TCF Capital's vision to build a new business ecosystem focused on longevity, providing Macromo with substantial backing and strategic partnership for future growth.

Keywords: preventative healthcare, personalized health, DNA testing, blood analysis, wearables data, health-tech, AI-driven health, longevity, mobile health, direct-to-consumer testing